AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

The model has uncovered a hidden layer of molecular code that shapes biological organization, adding new dimensions of ...

His team harnesses advanced computational technologies, including AI, with the aim of enhancing the discovery, design, optimization and synthesis of small molecules to be developed into innovative ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

AI is increasingly being adopted across healthcare and in 2025, it will be a driving force behind a smarter, nimbler, and ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence (AI). Traditionally, drug development has been a lengthy, costly, and ...

AI, and cloud computing towards improving existing computational methods while exploring new algorithms to address a wide range of drug design challenges. “We look forward to helping expedite ...